Central proliferation and neurogenesis is impaired in type 2 diabetes and prediabetes animal models

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Ramos Rodriguez, Juan Jose ^a   Molina Gil, Sara ^a   Ortiz Barajas, Oscar ^a   Jimenez Palomares, Margarita ^b   Perdomo, German ^c   Cozar Castellano, Irene ^b   Lechuga Sancho, Alfonso Maria ^a   Garcia Alloza, Monica ^a  

^a UNIVERSITY OF CÁDIZ   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

^c UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL; INSULIN; LEPTIN RECEPTOR; LEPTIN RECEPTOR, MOUSE;

ADULT; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DISEASE ASSOCIATION; DISEASE COURSE; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; HISTOPATHOLOGY; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; METABOLIC PARAMETERS; NERVOUS SYSTEM DEVELOPMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROGNOSIS; SUBVENTRICULAR ZONE; ANALYSIS; ANIMAL; BRAIN; DISEASE MODEL; ENZYME IMMUNOASSAY; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BLOOD GLUCOSE; BRAIN; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; IMMUNOENZYME TECHNIQUES; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, KNOCKOUT; MICE, OBESE; NEUROGENESIS; PREDIABETIC STATE; RECEPTORS, LEPTIN;

EID: 84895882964     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089229     Document Type: Article

References (51)

1. Forbes JM, Cooper ME (2013) Mechanisms of diabetic complications. Physiol Rev 93: 137-188.
2. Williamson R, McNeilly A, Sutherland C (2012) Insulin resistance in the brain: an old-age or new-age problem? Biochem Pharmacol 84: 737-745.
3. Kim B, Feldman EL (2012) Insulin resistance in the nervous system. Trends Endocrinol Metab 23: 133-141.
4. Craft S (2009) The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol 66: 300-305.
5. de la Monte SM (2012) Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease. Front Biosci (Elite Ed) 4: 1582-1605.
6. Kuljis RO, Salkovic-Petrisic M (2011) Dementia, diabetes, Alzheimer's disease, and insulin resistance in the brain: progress, dilemmas, new opportunities, and a hypothesis to tackle intersecting epidemics. J Alzheimers Dis 25: 29-41.
7. Hiltunen M, Khandelwal VK, Yaluri N, Tiilikainen T, Tusa M, et al. (2012) Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice. J Cell Mol Med 16: 1206-1222.
8. Takeda S, Sato N, Uchio-Yamada K, Sawada K, Kunieda T, et al. (2010) Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci U S A 107: 7036-7041.
9. Jimenez-Palomares M, Ramos-Rodriguez JJ, Lopez-Acosta JF, Pacheco-Herrero M, Lechuga-Sancho AM, et al. (2012) Increased Abeta production prompts the onset of glucose intolerance and insulin resistance. Am J Physiol Endocrinol Metab 11: 1373-1380.
10. Varela-Nallar L, Aranguiz FC, Abbott AC, Slater PG, Inestrosa NC (2010) Adult hippocampal neurogenesis in aging and Alzheimer's disease. Birth Defects Res C Embryo Today 90: 284-296.
11. Hamilton A, Holscher C (2012) The effect of ageing on neurogenesis and oxidative stress in the APP (swe)/PS1(deltaE9) mouse model of Alzheimer's disease. Brain Res 1449: 83-93.
12. Jin K, Peel AL, Mao XO, Xie L, Cottrell BA, et al. (2004) Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci U S A 101: 343-347. (Pubitemid 38084252)
13. Lang BT, Yan Y, Dempsey RJ, Vemuganti R (2009) Impaired neurogenesis in adult type-2 diabetic rats. Brain Res 1258: 25-33.
14. Jiang W, Gu W, Brannstrom T, Rosqvist R, Wester P (2001) Cortical neurogenesis in adult rats after transient middle cerebral artery occlusion. Stroke 32: 1201-1207. (Pubitemid 32825811)
15. Hamilton A, Patterson S, Porter D, Gault VA, Holscher C (2011) Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain. J Neurosci Res 89: 481-489.
16. Bruel-Jungerman E, Davis S, Rampon C, Laroche S (2006) Long-term potentiation enhances neurogenesis in the adult dentate gyrus. J Neurosci 26: 5888-5893. (Pubitemid 44318353)
17. Gault VA, Holscher C (2008) GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid. Eur J Pharmacol 587: 112-117.
18. McClean PL, Gault VA, Harriott P, Holscher C (2010) Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease. Eur J Pharmacol 630: 158-162.
19. Arvanitidis AP, Corbett D, Colbourne F (2009) A high fat diet does not exacerbate CA1 injury and cognitive deficits following global ischemia in rats. Brain Res 1252: 192-200.
20. Camargo N, Brouwers JF, Loos M, Gutmann DH, Smit AB, et al. (2012) High-fat diet ameliorates neurological deficits caused by defective astrocyte lipid metabolism. FASEB J 10: 4302-15.
21. Heyward FD, Walton RG, Carle MS, Coleman MA, Garvey WT, et al. (2012) Adult mice maintained on a high-fat diet exhibit object location memory deficits and reduced hippocampal SIRT1 gene expression. Neurobiol Learn Mem 98: 25-32.
22. Franklin KBJ, Paxinos G (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press United States.
23. Ramos-Rodriguez JJ, Ortiz O, Jimenez-Palomares M, Kay KR, Berrocoso E, et al. (2013) Differential central pathology and cognitive impairment in prediabetic and diabetic mice. Psychoneuroendocrinology 38: 2462-2475.
24. Alosco ML, Brickman AM, Spitznagel MB, Griffith EY, Narkhede A, et al. (2013) The adverse impact of type 2 diabetes on brain volume in heart failure. J Clin Exp Neuropsychol. 35: 309-18.
25. Brundel M, van den Heuvel M, de Bresser J, Kappelle LJ, Biessels GJ (2010) Cerebral cortical thickness in patients with type 2 diabetes. J Neurol Sci 299: 126-130.
26. Luchsinger JA, Tang MX, Shea S, Mayeux R (2004) Hyperinsulinemia and risk of Alzheimer disease. Neurology 63: 1187-1192. (Pubitemid 39350015)
27. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, et al. (1996) Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 39: 1392-1397. (Pubitemid 26356072)
28. Plastino M, Fava A, Pirritano D, Cotronei P, Sacco N, et al. (2010) Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2. J Neurol Sci 288: 112-116.
29. Schrijvers EM, Witteman JC, Sijbrands EJ, Hofman A, Koudstaal PJ, et al. (2010) Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study. Neurology 75: 1982-1987.
30. Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel JC, et al. (2012) An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Abeta oligomers. J Clin Invest 122: 1339-1353.
31. Dinel AL, Andre C, Aubert A, Ferreira G, Laye S, et al. (2011) Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome. PLoS One 6: e24325.
32. Wang Y, Nakagawa Y, Liu L, Wang W, Ren X, et al. (2011) Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes. Diabetologia 54: 440-450.
33. Jolivalt CG, Lee CA, Beiswenger KK, Smith JL, Orlov M, et al. (2008) Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin. J Neurosci Res 86: 3265-3274.
34. Kim B, Backus C, Oh S, Hayes JM, Feldman EL (2009) Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology 150: 5294-5301.
35. Ramos-Rodriguez JJ, Pacheco-Herrero M, Thyssen D, Murillo-Carretero MI, Berrocoso E, et al. (2013) Rapid beta-Amyloid Deposition and Cognitive Impairment After Cholinergic Denervation in APP/PS1 Mice. J Neuropathol Exp Neurol 72: 272-285.
36. Manschot SM, Brands AM, van der Grond J, Kessels RP, Algra A, et al. (2006) Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55: 1106-1113. (Pubitemid 44100188)
37. Mielke JG, Nicolitch K, Avellaneda V, Earlam K, Ahuja T, et al. (2006) Longitudinal study of the effects of a high-fat diet on glucose regulation, hippocampal function, and cerebral insulin sensitivity in C57BL/6 mice. Behav Brain Res 175: 374-382. (Pubitemid 44781116)
38. Uetsuka K, Shirai M, Yamauchi H, Nakayama H, Doi K (2005) Impaired proliferation of non-parenchymal cells participates in an impairment of liver regeneration in db/db mice. Exp Mol Pathol 79: 51-58. (Pubitemid 40984752)
39. Zhao Z, Choi J, Zhao C, Ma ZA (2012) FTY720 normalizes hyperglycemia by stimulating beta-cell in vivo regeneration in db/db mice through regulation of cyclin D3 and p57(KIP2). J Biol Chem 287: 5562-5573.
40. Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM, et al. (2008) Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci 11: 309-317. (Pubitemid 351311802)
41. Hunter K, Holscher C (2012) Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. BMC Neurosci 13: 33.
42. Camargo N, Brouwers JF, Loos M, Gutmann DH, Smit AB, et al. (2012) High-fat diet ameliorates neurological deficits caused by defective astrocyte lipid metabolism. FASEB J 26: 4302-4315.
43. Barella LF, de Oliveira JC, Branco RC, Camargo RL, Gomes RM, et al. (2012) Early exposure to a high-fat diet has more drastic consequences on metabolism compared with exposure during adulthood in rats. Horm Metab Res 44: 458-464.
44. Machida M, Fujimaki S, Hidaka R, Asashima M, Kuwabara T (2012) The insulin regulatory network in adult hippocampus and pancreatic endocrine system. Stem Cells Int 2012: 959737.
45. McNay EC (2007) Insulin and ghrelin: peripheral hormones modulating memory and hippocampal function. Curr Opin Pharmacol 7: 628-632.
46. Pan W, Hsuchou H, Jayaram B, Khan RS, Huang EY, et al. (2012) Leptin action on nonneuronal cells in the CNS: potential clinical applications. Ann N Y Acad Sci 1264: 64-71.
47. Doherty GH, Oldreive C, Harvey J (2008) Neuroprotective actions of leptin on central and peripheral neurons in vitro. Neuroscience 154: 1297-1307.
48. Weng Z, Signore AP, Gao Y, Wang S, Zhang F, et al. (2007) Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling. J Biol Chem 282: 34479-34491. (Pubitemid 350159488)
49. Haan MN (2006) Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease. Nat Clin Pract Neurol 2: 159-166.
50. Manschot SM, Biessels GJ, de Valk H, Algra A, Rutten GE, et al. (2007) Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 50: 2388-2397. (Pubitemid 47512398)
51. Raji CA, Ho AJ, Parikshak NN, Becker JT, Lopez OL, et al. (2010) Brain structure and obesity. Hum Brain Mapp 31: 353-364.